Efficacy and Safety of Anifrolumab compared to placebo in adult subjects with Active Systemic Lupus Erythematosus

Trial Identifier: D3461C00004
Sponsor: AstraZeneca
Collaborator:
PRA Health Sciences
NCTID:: NCT02446899
Start Date: July 2015
Primary Completion Date: September 2018
Study Completion Date: September 2018
Condition: Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations